Błaszczak, E.; Miziak, P.; Odrzywolski, A.; Baran, M.; Gumbarewicz, E.; Stepulak, A.
Triple-Negative Breast Cancer Progression and Drug Resistance in the Context of Epithelial–Mesenchymal Transition. Cancers 2025, 17, 228.
https://doi.org/10.3390/cancers17020228
AMA Style
Błaszczak E, Miziak P, Odrzywolski A, Baran M, Gumbarewicz E, Stepulak A.
Triple-Negative Breast Cancer Progression and Drug Resistance in the Context of Epithelial–Mesenchymal Transition. Cancers. 2025; 17(2):228.
https://doi.org/10.3390/cancers17020228
Chicago/Turabian Style
Błaszczak, Ewa, Paulina Miziak, Adrian Odrzywolski, Marzena Baran, Ewelina Gumbarewicz, and Andrzej Stepulak.
2025. "Triple-Negative Breast Cancer Progression and Drug Resistance in the Context of Epithelial–Mesenchymal Transition" Cancers 17, no. 2: 228.
https://doi.org/10.3390/cancers17020228
APA Style
Błaszczak, E., Miziak, P., Odrzywolski, A., Baran, M., Gumbarewicz, E., & Stepulak, A.
(2025). Triple-Negative Breast Cancer Progression and Drug Resistance in the Context of Epithelial–Mesenchymal Transition. Cancers, 17(2), 228.
https://doi.org/10.3390/cancers17020228